Suivant

Lecture automatique

Dr. Robin Jones on Olaratumab and Doxorubicin in Patients with Soft Tissue Sarcoma

3 Vues • 07/18/23
Partager
Intégrer
administrator
administrator
Les abonnés
0

Robin Jones, BSc, MB, MRCP, MD, oncologist, Royal Marsden Hospital, London, discusses the effectiveness of monoclonal antibody olaratumab in combination with doxorubicin in unresectable and metastatic soft tissue sarcoma.

For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/

Montre plus
0 commentaires sort Trier par
Commentaires de Facebook

Suivant

Lecture automatique